Strongyloides IgG/IgM ELISA

Enzyme immunoassay for the qualitative determination of antibodies against Strongyloides in human serum or plasma.

INTENDED USE:The Strongyloides ELISA is intended for the qualitative determination of antibodies against Strongyloides in human serum or plasma (citrate or heparin).

GENERAL INFORMATION:The qualitative immunoenzymatic determination of specific antibodies is based on the ELISA (Enzyme-linked Immunosorbent Assay) technique. Microtiterplates are coated with specific antigens to bind corresponding antibodies of the sample. After washing the wells to remove all unbound sample material a horseradish peroxidase (HRP) labelled conjugate is added. This conjugate binds to the captured antibodies. In a second washing step unbound conjugate is removed. The immune complex formed by the bound conjugate is visualized by adding Tetramethylbenzidine (TMB) substrate which gives a blue reaction product. The intensity of this product is proportional to the amount of specific antibodies in the sample. Sulphuric acid is added to stop the reaction. This produces a yellow endpoint colour. Absorbance at 450/620 nm is read using an ELISA Microtiterplate reader.

KIT CHARACTERISTICS:
- Method: ELISA
- Tests: 96
- Incubation Time / Conditions: 1 h (37°C), 30 min (RT), 15 min (RT/dark)
- Standard Range: Cut-off
- Sensitivity analytical: diagn. 89.47 %
- Final Sample Volume: 100 µl
- Sample Type: serum, plasma (citrate, heparin)
- Sample Pretreatment: 1:101 diluted
- Isotope / Substrate: TMB 450 nm
- Regulatory Status: CE/RUO